Shopping Cart
- Remove All
- Your shopping cart is currently empty
PF-07284892 (ARRY-558) is an orally active, potent SHP2 inhibitor with an IC50 of 21 nM, known to reduce the expression of pERK [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 8-10 weeks | |
50 mg | $1,980 | 8-10 weeks | |
100 mg | $2,500 | 8-10 weeks |
Description | PF-07284892 (ARRY-558) is an orally active, potent SHP2 inhibitor with an IC50 of 21 nM, known to reduce the expression of pERK [1] [2]. |
In vitro | PF-07284892 (100 nM; 4, 18 h), in combination with lorlatinib (0-450 nM) or binimetinib (0-160 nM), reduces pERK expression in H3122 lorR-06 and VACO-432 cells [2]. |
In vivo | PF-07284892 (10 mg/kg; p.o.) exhibited high oral bioavailability, with F% values of 85% in mice, 94% in rats, 102% in dogs, and 64% in monkeys [2]. |
Alias | ARRY-558 |
Molecular Weight | 439.96 |
Formula | C21H22ClN7S |
Cas No. | 2498597-94-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.